Quick Takeaways
- GREAT POINT PARTNERS LLC filed SCHEDULE 13G/A for VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR).
- Disclosed ownership: 3.3%.
- Date of event: 31 Dec 2025.
GREAT POINT PARTNERS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR)
- Filing Manager
- GREAT POINT PARTNERS LLC
- Reporting Manager
- Great Point Partners, LLC
- Symbol
- VOR
- Shares outstanding
- 41,518,394 shares
- Disclosed Ownership
- 1,370,107 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:13:56 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 17 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GREAT POINT PARTNERS LLC disclosed 3.3% ownership in VOR BIOPHARMA INC. Common Stock, $0.0001 par value per share (VOR) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 17 Dec 2025.
- Current filing was accepted on 17 Feb 2026, 16:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Great Point Partners, LLC | 3.3% | 1,370,107 | 0 | 1,370,107 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D - Senior Managing Member | |
| Dr. Jeffrey R. Jay, M.D. | 3.3% | 1,370,107 | 0 | 1,370,107 | /s/ Dr. Jeffrey R. Jay, M.D | Dr. Jeffrey R. Jay, M.D | |
| Ms. Lillian Nordahl | 3.3% | 1,370,107 | 0 | 1,370,107 | /s/ Ms. Lillian Nordahl | Ms. Lillian Nordahl |